Deep-pocketed investors have adopted a bearish approach towards Moderna (NASDAQ:MRNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

In early trading on Monday, shares of Moderna topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.4%. Year to date, Moderna has lost about 45.3% of its value.

In trading on Monday, shares of Moderna Inc (Symbol: MRNA) entered into oversold territory, hitting an RSI reading of 29.3, after changing hands as low as $53.41 per share. By comparison ...

Below is a chart showing LLY's trailing twelve month trading history, with the $830 strike highlighted in orange: Moderna Inc (Symbol: MRNA) options are showing a volume of 68,653 contracts thus ...

Below is Validea's guru fundamental report for MODERNA INC (MRNA). Of the 22 guru strategies we follow, MRNA rates highest using our Value Investor model based on the published strategy of ...

The upcoming report from Moderna (MRNA) is expected to reveal quarterly loss of $1.91 per share, indicating a decline of 37.4% compared to the year-ago period. Analysts forecast revenues of $1.25 ...

In the latest market close, Moderna (MRNA) reached $54.36 ... Meanwhile, the Dow lost 0.9%, and the Nasdaq, a tech-heavy index, lost 2.76%. The biotechnology company's shares have seen a decrease ...

Moderna (MRNA) reported $1.86 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 1.7%. EPS of $0.03 for the same period compares to -$1.39 a year ago.

Moderna (MRNA) closed the latest trading day at $ ... Meanwhile, the Dow experienced a drop of 0.37%, and the technology-dominated Nasdaq saw an increase of 0.78%. Prior to today's trading, shares ...

The latest trading session saw Moderna (MRNA) ending at $53.80 ... Elsewhere, the Dow lost 0.8%, while the tech-heavy Nasdaq added 0.27%. Prior to today's trading, shares of the biotechnology ...

Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the December 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...